Cardiol Therapeutics Inc Class A (CRDL : TSX)
Common Stock
Follow CRDL
CRDL
Cardiol Therapeutics Inc Class A
Performance
1 Day
-5.44%
1 Week
-6.08%
1 Month
-12.03%
YTD
+2.21%
The Saturday TSX Wrap · free, every saturday morning. The week on the TSX, in five minutes.
Key Statistics
Market Cap
$174.98M
52W High
$3.23
52W Low
$1.23
P/E Ratio
-
50 Day MA
$2.15
200 Day MA
$1.81
Beta
0.66
Dividend Yield
-
WA Score
How CRDL stacks up against 944 Canadian stocks
out of 99
- Value9
Not profitable over the last 12 months.
- Quality
- Momentum35
2.2% this year, below its 200-day average, 8% of the way up its 52-week range.
- Analysts
- Insiders
Each factor is a percentile against Canadian common stocks worth $50M or more on the TSX and TSX Venture (90 = better than 90% of them). Built from exchange prices, company financials, analyst targets and SEDI insider filings. A data summary, not advice. How it works · Top-scoring stocks
Performance history
CRDL returns since 2023
Cardiol Therapeutics Inc Class A has traded since Nov 2023 in our data, with 1 up year out of 2 full calendar years. Its deepest fall was −70.8% (Jun 2024 to Apr 2025).
1 year / yr
0.0%
3 years / yr
+6.8%
5 years / yr
—
10 years / yr
—
Calendar-year returns
- 2023*+3.8%
- 2024+68.2%
- 2025−29.2%
- 2026*+6.1%
* Partial year (first year of data, or year to date).
$10,000 invested in CRDL
- 1 year ago$10,000
- 2023 (start of our data)$13,113
- Best year
- 2024: +68.2%
- Worst year
- 2025: −29.2%
- All-time high in our data
- $4 on Jun 12, 2024 · now −65.8%
Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Nov 2023 to Nov 2026. Past returns do not predict future ones.
Earnings
CRDL earnings history
Cardiol Therapeutics Inc Class A beat the EPS estimate in 3 of its last 4 reported quarters.
| Quarter ending | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 30, 2026 | Nov 12, 2026 | −$0.08 | −$0.08 | −6.7% |
| Jun 30, 2026 | Aug 12, 2026 | −$0.05 | −$0.10 | +50.0% |
| Mar 31, 2026 | May 12, 2026 | −$0.07 | −$0.09 | +20.1% |
| Dec 31, 2025 | Mar 31, 2026 | −$0.07 | −$0.11 | +36.4% |
| Sep 30, 2025 | Nov 13, 2025 | −$0.12 | −$0.10 | −20.0% |
| Jun 30, 2025 | Aug 14, 2025 | −$0.10 | −$0.12 | +16.7% |
| Mar 31, 2025 | May 14, 2025 | −$0.10 | −$0.13 | +23.1% |
| Dec 31, 2024 | Mar 31, 2025 | −$0.09 | −$0.12 | +22.9% |
EPS as reported vs consensus estimate. TSX earnings calendar →
Awesome Portfolio™
Looking past CRDL? Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/16/2026 | $1.43 | $1.43 | $1.38 | $1.39 | $1.39 | 53,341 |
| 11/13/2026 | $1.46 | $1.47 | $1.41 | $1.47 | $1.47 | 38,978 |
| 11/12/2026 | $1.46 | $1.49 | $1.40 | $1.47 | $1.47 | 85,641 |
| 11/11/2026 | $1.49 | $1.52 | $1.44 | $1.46 | $1.46 | 45,715 |
| 11/10/2026 | $1.49 | $1.49 | $1.44 | $1.44 | $1.44 | 80,114 |
| 11/9/2026 | $1.41 | $1.49 | $1.37 | $1.48 | $1.48 | 96,945 |
| 11/6/2026 | $1.38 | $1.41 | $1.33 | $1.41 | $1.41 | 63,545 |
| 11/5/2026 | $1.44 | $1.46 | $1.29 | $1.33 | $1.33 | 113,301 |
| 11/4/2026 | $1.51 | $1.51 | $1.41 | $1.44 | $1.44 | 79,884 |
| 11/3/2026 | $1.47 | $1.50 | $1.46 | $1.50 | $1.50 | 68,331 |
Analyst Price Targets
Based on analyst covering CRDL · as of Oct 12, 2026
Wall Street analysts forecast CRDL stock price to rise 614.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.00
+614.4% Upside
Previously C$6.00 on Sep 17, 2026
Current Price
C$0.98
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CRDL's historical volatility
30-Day Vol
58.4%
Annualized
90-Day Vol
71.5%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$1.16
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.31 | C$1.07 – C$1.60 |
| 60 trading days | C$1.23 | C$0.93 – C$1.64 |
| 90 trading days | C$1.16 | C$0.82 – C$1.65 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Cardiol Therapeutics Inc Class A
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-35.85M
- Profit Margin
- 0.00%
- ROE (TTM)
- -190.18%
- EPS (Diluted)
- -0.35
- Book Value
- 0.21
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Free newsletter
The Saturday TSX Wrap
The week on the TSX, in five minutes
- The biggest gainers and losers, and why they moved
- Sector and momentum moves at a glance
- The Canadian market stories you missed
Explore More
Common Questions About CRDL
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| HWO | High Arctic Energy Services Inc. | $1.74 | +29.85% |
| AAV | Advantage Oil & Gas Ltd. | $13.45 | +23.74% |
| LUC | Lucara Diamond Corp | $0.13 | +13.64% |
| T | Telus Corp | $13.70 | +12.85% |
| FRX | Fennec Pharmaceuticals Inc | $18.35 | +10.81% |
| KEL | Kelt Exploration Ltd. | $12.72 | +10.70% |
| NVO | Novo Resources Corp | $0.07 | +8.33% |
| ELO | Eloro Resources Ltd. | $1.23 | +7.89% |
Free with a Wealth Awesome account
Keep analysing CRDL, free
- Every WA Score, ranking and table
- Insider track records and SEDI filings
- Earnings history and analyst targets for every stock
Email only, no password, no card. Already a member? Use the same button to sign in.
